Nolla provides a mobile‑first dermatology platform that uses Vision‑Transformer AI to analyze skin photos and generate clinician‑reviewed treatment plans, including custom‑compounded topical prescriptions shipped to users. The service offers real‑time image assessment, longitudinal skin‑tracking, and HIPAA‑compliant data handling, eliminating in‑person visits and insurance intermediaries. Pricing is subscription‑based with a free initial scan and per‑assessment fees.
Funding
$4.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many people experience long wait times, geographic barriers, and out‑of‑pocket costs when seeking dermatology care for common skin conditions such as acne or suspicious moles. Traditional clinic visits also require scheduling, transportation, and repeated in‑person assessments to monitor progress. These frictions delay diagnosis and treatment, reducing clinical outcomes and patient satisfaction.
Solution
Nolla delivers a mobile‑first dermatology service that combines proprietary AI models with licensed clinician oversight. Users capture a photo of their skin using an iOS device; Vision‑Transformer and multimodal deep‑learning algorithms evaluate acne severity, oiliness, inflammation, or mole risk in seconds. The AI output is reviewed by a board‑certified dermatologist who authorizes a personalized treatment plan, which may include a custom‑compounded topical prescription shipped directly to the user. The platform continuously tracks skin changes, updates the care plan as needed, and stores all data in a HIPAA‑compliant cloud environment. This end‑to‑end workflow eliminates the need for waiting rooms, referrals, or insurance intermediaries while maintaining clinical quality.
Target Audience
The service targets U.S. and Norwegian consumers who want fast, clinically vetted care for acne or mole assessment without visiting a dermatologist in person. It is also suitable for individuals seeking ongoing skin‑health monitoring and prescription delivery at home.
Features
- Vision Transformer‑based image analysis pipeline that scores acne severity (IGA/GAGS) and flags high‑risk lesions with >93% R² correlation to expert ratings.
- Automated image‑quality assessment to ensure clinical‑grade photos before AI processing.
- Real‑time AI inference on the device followed by asynchronous review by a licensed dermatologist.
- Custom‑compounded topical prescriptions (e.g., tretinoin, clindamycin, azelaic acid) generated per‑patient and shipped via USPS.
- Longitudinal skin‑tracking dashboard that visualizes severity scores, treatment adherence, and photographic progress.
- End‑to‑end encryption, role‑based access controls, and full HIPAA compliance for data storage and transmission.
- Subscription‑based pricing model with a free initial scan and transparent monthly fees.